paramethadione
Sign in to saveAlso known as isoethadione
Paramethadione (brand name Paradione) is an anticonvulsant drug of the chemical class called oxazolidinediones developed by the Illinois-based pharmaceutical company Abbott Laboratories (known as AbbVie since January 1, 2013 ), and approved by the Food and Drug Administration in 1949 for the treatment of absence seizures, also called partial seizures.
~3 min read
Encyclopedic overview
9 sectionsContents
- Mechanism of Action
- Adverse Effects
- History, society, and culture
- FDA approval
- Patents
- Clinical Trials
- Chemistry
- References
- External links
Paramethadione (brand name Paradione) is an anticonvulsant drug of the chemical class called oxazolidinediones developed by the Illinois-based pharmaceutical company Abbott Laboratories (known as AbbVie since January 1, 2013 ), and approved by the Food and Drug Administration in 1949 for the treatment of absence seizures, also called partial seizures.
In 1960, the yearly cost for 900 mg/day paramethadione was approximately $66, which would translate to $462 yearly in 2007 (with CPI inflation) if paramethadione was still sold.
Excerpted from Wikipedia’s “paramethadione” article, available under the CC BY-SA 4.0 licence.